INTSINTENSITY THERAPEUTICS, INC.

$3.77
$0.03
(0.81%)
Today
Closed $3.74
$0.03
(0.80%)
After Hours
Updated: 05:30 PM EDT
Reported EarningsMay 7
Mkt Cap$10.03M
Vol14,049.00

About

Intensity Therapeutics, Inc. is a clinical-stage biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting of an amphiphilic cell penetration enhancer molecule combined with cisplatin and vinblastine. The company was founded by Lewis H. Bender in 2012 and is headquartered in Shelton, CT.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
16

Frequently Asked Questions

What is Market Cap of Intensity Therapeutics Inc?
What is the 52-week high for Intensity Therapeutics Inc?
What is the 52-week low for Intensity Therapeutics Inc?
What is Intensity Therapeutics Inc stock price today?
What was Intensity Therapeutics Inc stock price yesterday?
What is the PE ratio of Intensity Therapeutics Inc?
What is the Price-to-Book ratio of Intensity Therapeutics Inc?
What is the 50-day moving average of Intensity Therapeutics Inc?
How many employees does Intensity Therapeutics Inc have?

Advertisement|Remove ads.